Figure 2.
VWF multimer distribution in children with SCD treated with hydroxycarbamide compared to blood transfusion. (A) Representative images of VWF multimer distribution in HC and BT cohorts. Percentage of (B) high-, (C) intermediate-, and (D) low-molecular-weight VWF multimers. Comparisons between groups were assessed by the Mann-Whitney U test. Dotted red lines represent the percentage of high-, intermediate-, and low-molecular-weight multimers in normal pooled plasma (NPP); ∗P < .05, ∗∗∗P < .001, and ∗∗∗∗P < .0001.

VWF multimer distribution in children with SCD treated with hydroxycarbamide compared to blood transfusion. (A) Representative images of VWF multimer distribution in HC and BT cohorts. Percentage of (B) high-, (C) intermediate-, and (D) low-molecular-weight VWF multimers. Comparisons between groups were assessed by the Mann-Whitney U test. Dotted red lines represent the percentage of high-, intermediate-, and low-molecular-weight multimers in normal pooled plasma (NPP); ∗P < .05, ∗∗∗P < .001, and ∗∗∗∗P < .0001.

Close Modal

or Create an Account

Close Modal
Close Modal